Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed)

The Academic Career Excellence (ACE) Award (K32) is administered by the National Institutes of Health (NIH), an agency within the U.S. Department of Health and Human Services. NIH is the primary federal agency responsible for conducting and supporting medical research to improve public health. Through its extramural research programs, NIH funds institutions and researchers across the United States to advance scientific knowledge in areas such as cancer, neuroscience, infectious diseases, and technological innovation in health. The ACE Award aligns with NIH’s mission by investing in early-stage researchers and strengthening the biomedical research workforce. The purpose of the ACE Award is to support rigorous, mentored scientific research and career development for early-stage postdoctoral scholars. This program provides up to three years of support to individuals who are either preparing to begin a postdoctoral position or are within the first two years of their postdoctoral training. The program emphasizes early planning, innovation, and the development of independent research careers. It is designed to foster high-impact research ideas without requiring preliminary data, instead prioritizing strong conceptual frameworks and mentorship plans. Funding provided through this award supports a combination of research and career development activities. Allowable uses typically include salary support, research expenses, and training-related costs necessary to execute the proposed project and professional development plan. The program explicitly does not require cost sharing or matching funds, reducing financial barriers for applicants and institutions. While specific award amounts and total funding levels are not stated in the synopsis, the focus remains on enabling scholars to build a strong foundation for future independent research funding. Eligibility for the ACE Award is broad in terms of institutional types but specific in terms of applicant qualifications. Eligible applicants include a wide range of U.S.-based entities such as state and local governments, nonprofits, small businesses, for-profit organizations, tribal governments, and institutions of higher education. However, foreign organizations are not eligible to apply, although foreign components within U.S. organizations may be permitted under NIH policy. Individual candidates must meet timing requirements related to their postdoctoral training, applying either within one year prior to starting or within two years of beginning their postdoctoral position. The application process requires submission through NIH’s established grant mechanisms, typically via Grants.gov and associated systems. Applicants must prepare a comprehensive proposal that includes a research plan, career development plan, and mentorship structure. Although preliminary data are not required, applications must demonstrate innovation, feasibility, and a strong alignment with NIH priorities. Evaluation criteria focus on the candidate’s potential, the quality of the research plan, the strength of the mentorship team, and the overall likelihood of the applicant developing into an independent investigator. The application timeline indicates that the opportunity is currently open, with a closing date of July 12, 2029. The opportunity appears to follow a recurring or long-term solicitation model typical of NIH career development awards, allowing multiple submission cycles within the active period. Applicants are encouraged to plan submissions carefully in alignment with their postdoctoral timelines. For additional information or assistance, applicants may contact the National Cancer Institute’s Center for Cancer Training via the provided email address. This program plays a critical role in building the next generation of biomedical researchers by supporting innovative ideas and structured career development pathways.